The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy
Open accessAbstract
// Brock Humphries 1, 2 , Chengfeng Yang 1, 2, 3 1 Department of Physiology, Michigan State University, East Lansing, MI 48824, USA 2 Cellular and Molecular Biology Graduate Program, Michigan State University, East Lansing, MI 48824, USA 3 Center for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, USA Correspondence to: Chengfeng Yang, e-mail: yangcf@msu.edu Keywords: microRNA, miR-200, cancer initiation, cancer metastasis, cancer therapeutic target Received: November 14, 2014 Accepted: January 06, 2015 Published: January 30, 2015 ABSTRACT MicroRNAs (miRNAs) are a large family of small non-coding RNAs that negatively regulate protein-coding gene expression post-transcriptionally via base pairing between the 5′ seed region of a miRNA and the 3′ untranslated region (3′UTR) of a messenger RNA (mRNA). Recent evidence has supported the critical role that miRNAs play in many diseases including cancer. The miR-200 family consisting of 5 members (miR-200a, -200b, -200c, -141, -429) is an emerging miRNA family that has been shown to play crucial roles in cancer initiation and metastasis, and potentially be important for the diagnosis and treatment of cancer. While miR-200s were found to be critically involved in the metastatic colonization to the lungs in mouse mammary xenograft tumor models, a large number of studies demonstrated their strong suppressive effects on cell transformation, cancer cell proliferation, migration, invasion, tumor growth and metastasis. This review aims to discuss research findings about the role of the miR-200 family in cancer initiation, each step of cancer metastatic cascade, cancer diagnosis and treatment. A comprehensive summary of currently validated miR-200 targets is also presented. It is concluded that miR-200 family may serve as novel targets for the therapy of multiple types of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“In addition to these mechanisms, new blood vessels that have been formed by the primary tumor are leaky and therefore can also facilitate intravasation [70, 71].”
BackgroundThe nuclear RNase III Drosha initiates microRNA processing
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S., et al. (2003) · Nature · doi:10.1038/nature01957 · Cited by 5,114
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Identification of Novel Genes Coding for Small Expressed RNAs
Lagos-Quintana, M., Rauhut, R., Lendeckel, W., & Tuschl, T. (2001) · Science · doi:10.1126/science.1064921 · Cited by 4,956
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686 · cited 1×
“Metastasis can be broken down into 6 steps [38]: 1) growth and vascularization of the primary tumor, and nearby tissue invasion, 2) detachment of the cancer cells and migration away from the primary tumor, 3) intravasation into the blood stream and lymph nodes, 4) survival and circularization within the blood stream a…”
BackgroundChen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
MicroRNA genes are transcribed by RNA polymerase II
Lee, Y., Kim, M., Han, J., Yeom, K., Lee, S., Baek, S. H., & Kim, V. N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600385 · Cited by 4,373
Wightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
The impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429 · cited 1×
“Down-regulation of mRNAs through miRNA-caused mRNA destabilization and degradation is common, which is usually mediated by the same imperfect miRNA:mRNA base pairing that leads to translational inhibition [18–20].”
BackgroundAn Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans
Lau, N. C., Lim, L. P., Weinstein, E. G., & Bartel, D. P. (2001) · Science · doi:10.1126/science.1065062 · Cited by 3,345
An Extensive Class of Small RNAs in Caenorhabditis elegans
Lee, R. C., & Ambros, V. (2001) · Science · doi:10.1126/science.1065329 · Cited by 2,922
Hutvágner, G., McLachlan, J., Pasquinelli, A. E., Bálint, E., Tuschl, T., & Zamore, P. D. (2001) · Science · doi:10.1126/science.1062961 · Cited by 2,781
Principles of MicroRNA–Target Recognition
Brennecke, J., Stark, A., Russell, R. B., & Cohen, S. M. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030085 · Cited by 2,378
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
The Drosha-DGCR8 complex in primary microRNA processing
Han, J., Lee, Y., Yeom, K.-H., Kim, Y.-K., Jin, H., & Kim, V. N. (2004) · Genes & Development · doi:10.1101/gad.1262504 · Cited by 2,220
Grishok, A., Pasquinelli, A. E., Conte, D., Li, N., Parrish, S., Ha, I., Baillie, D. L., Fire, A., Ruvkun, G., & Mello, C. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00431-7 · Cited by 1,908
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,876
CAI, X., HAGEDORN, C. H., & CULLEN, B. R. (2004) · RNA · doi:10.1261/rna.7135204 · Cited by 1,872
Garzon, R., Calin, G. A., & Croce, C. M. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.59.053006.104707 · Cited by 1,770
Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., Banham, A. H., Pezzella, F., Boultwood, J., Wainscoat, J. S., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07077.x · Cited by 1,735
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO reports · doi:10.1038/embor.2008.74 · Cited by 1,722
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800074200 · Cited by 1,645
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael, M., Connor, S. M. O., Pellekaan, N. V. H., Young, G. P., & James, R. J. (2003) · PubMed · Cited by 1,581
The Two-Handed E Box Binding Zinc Finger Protein SIP1 Downregulates E-Cadherin and Induces Invasion
Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., & van Roy, F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00260-x · Cited by 1,394
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Shimono, Y., Zabala, M., Cho, R. W., Lobo, N., Dalerba, P., Qian, D., Diehn, M., Liu, H., Panula, S. P., Chiao, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.07.011 · Cited by 1,213
Repression of protein synthesis by miRNAs: how many mechanisms?
Pillai, R. S., Bhattacharyya, S. N., & Filipowicz, W. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.12.007 · Cited by 1,108
Bracken, C. P., Gregory, P. A., Kolesnikoff, N., Bert, A. G., Wang, J., Shannon, M. F., & Goodall, G. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1942 · Cited by 1,060
Direct Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary Tumors
Wyckoff, J. B., Wang, Y., Lin, E. Y., Li, J.-F., Goswami, S., Stanley, E. R., Segall, J. E., Pollard, J. W., & Condeelis, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1823 · Cited by 1,053
Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.057 · Cited by 984
Detection and Characterization of Placental MicroRNAs in Maternal Plasma
Chim, S. S. C., Shing, T. K. F., Hung, E. C. W., Leung, T.-Y., Lau, T.-K., Chiu, R. W. K., & Dennis Lo, Y. M. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097972 · Cited by 850
Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection
Park, N. J., Zhou, H., Elashoff, D., Henson, B. S., Kastratovic, D. A., Abemayor, E., & Wong, D. T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0736 · Cited by 843
Eger, A., Aigner, K., Sonderegger, S., Dampier, B., Oehler, S., Schreiber, M., Berx, G., Cano, A., Beug, H., & Foisner, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208429 · Cited by 808
Clustering and conservation patterns of human microRNAs
Altuvia, Y. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki567 · Cited by 802
p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs
Chang, C.-J., Chao, C.-H., Xia, W., Yang, J.-Y., Xiong, Y., Li, C.-W., Yu, W.-H., Rehman, S. K., Hsu, J. L., Lee, H.-H., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2173 · Cited by 745
Korpal, M., Ell, B. J., Buffa, F. M., Ibrahim, T., Blanco, M. A., Celià-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2401 · Cited by 636
Kovalchuk, O., Filkowski, J., Meservy, J., Ilnytskyy, Y., Tryndyak, V. P., Chekhun, V. F., & Pogribny, I. P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0021 · Cited by 635
Vitale, A. V., Tan, H., & Jin, P. (2011) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2011.2236 · Cited by 623
Aigner, K., Dampier, B., Descovich, L., Mikula, M., Sultan, A., Schreiber, M., Mikulits, W., Brabletz, T., Strand, D., Obrist, P., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210508 · Cited by 617
Circulating miRNAs are correlated with tumor progression in prostate cancer
Brase, J. C., Johannes, M., Schlomm, T., Fälth, M., Haese, A., Steuber, T., Beissbarth, T., Kuner, R., & Sültmann, H. (2011) · International Journal of Cancer · doi:10.1002/ijc.25376 · Cited by 587
Zhao, C. Q., Young, M. R., Diwan, B. A., Coogan, T. P., & Waalkes, M. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10907 · Cited by 559
The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity
Glavinas, H., Krajcsi, P., Cserepes, J., & Sarkadi, B. (2004) · Current Drug Delivery · doi:10.2174/1567201043480036 · Cited by 558
p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
Kim, T., Veronese, A., Pichiorri, F., Lee, T. J., Jeon, Y.-J., Volinia, S., Pineau, P., Marchio, A., Palatini, J., Suh, S.-S., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110235 · Cited by 514
Gibbons, D. L., Lin, W., Creighton, C. J., Rizvi, Z. H., Gregory, P. A., Goodall, G. J., Thilaganathan, N., Du, L., Zhang, Y., Pertsemlidis, A., et al. (2009) · Genes & Development · doi:10.1101/gad.1820209 · Cited by 512
Eichhorn, S. W., Guo, H., McGeary, S. E., Rodriguez-Mias, R. A., Shin, C., Baek, D., Hsu, S.-H., Ghoshal, K., Villén, J., & Bartel, D. P. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.028 · Cited by 503
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Mateescu, B., Batista, L., Cardon, M., Gruosso, T., de Feraudy, Y., Mariani, O., Nicolas, A., Meyniel, J.-P., Cottu, P., Sastre-Garau, X., et al. (2011) · Nature Medicine · doi:10.1038/nm.2512 · Cited by 502
miR-200–containing extracellular vesicles promote breast cancer cell metastasis
Le, M. T. N., Hamar, P., Guo, C., Basar, E., Perdigão-Henriques, R., Balaj, L., & Lieberman, J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75695 · Cited by 449
Cheng, H., Zhang, L., Cogdell, D. E., Zheng, H., Schetter, A. J., Nykter, M., Harris, C. C., Chen, K., Hamilton, S. R., & Zhang, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017745 · Cited by 430
Adam, L., Zhong, M., Choi, W., Qi, W., Nicoloso, M., Arora, A., Calin, G., Wang, H., Siefker-Radtke, A., McConkey, D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2245 · Cited by 412
Tumour angiogenesis regulation by the miR-200 family
Pecot, C. V., Rupaimoole, R., Yang, D., Akbani, R., Ivan, C., Lu, C., Wu, S., Han, H.-D., Shah, M. Y., Rodriguez-Aguayo, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3427 · Cited by 402
Iliopoulos, D., Lindahl-Allen, M., Polytarchou, C., Hirsch, H. A., Tsichlis, P. N., & Struhl, K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.08.013 · Cited by 399
The ZEB1/miR‐200 feedback loop controls Notch signalling in cancer cells
Brabletz, S., Bajdak, K., Meidhof, S., Burk, U., Niedermann, G., Firat, E., Wellner, U., Dimmler, A., Faller, G., Schubert, J., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.349 · Cited by 369
Clinical Applications for microRNAs in Cancer
Nana-Sinkam, S. P., & Croce, C. M. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.192 · Cited by 352
MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
Hummel, R., Hussey, D. J., & Haier, J. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.027 · Cited by 344
Pogribny, I. P., Filkowski, J. N., Tryndyak, V. P., Golubov, A., Shpyleva, S. I., & Kovalchuk, O. (2010) · International Journal of Cancer · doi:10.1002/ijc.25191 · Cited by 334
McArthur, K., Feng, B., Wu, Y., Chen, S., & Chakrabarti, S. (2011) · Diabetes · doi:10.2337/db10-1557 · Cited by 329
miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases
Dykxhoorn, D. M., Wu, Y., Xie, H., Yu, F., Lal, A., Petrocca, F., Martinvalet, D., Song, E., Lim, B., & Lieberman, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007181 · Cited by 324
Cochrane, D. R., Spoelstra, N. S., Howe, E. N., Nordeen, S. K., & Richer, J. K. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1046 · Cited by 320
miR-200a Regulates Nrf2 Activation by Targeting Keap1 mRNA in Breast Cancer Cells
Eades, G., Yang, M., Yao, Y., Zhang, Y., & Zhou, Q. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.275495 · Cited by 305
Tellez, C. S., Juri, D. E., Do, K., Bernauer, A. M., Thomas, C. L., Damiani, L. A., Tessema, M., Leng, S., & Belinsky, S. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3035 · Cited by 277
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
Hu, X., Macdonald, D. M., Huettner, P. C., Feng, Z., El Naqa, I. M., Schwarz, J. K., Mutch, D. G., Grigsby, P. W., Powell, S. N., & Wang, X. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.05.022 · Cited by 275
Saydam, O., Shen, Y., Würdinger, T., Senol, O., Boke, E., James, M. F., Tannous, B. A., Stemmer-Rachamimov, A. O., Yi, M., Stephens, R. M., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00332-09 · Cited by 255
Targets of miR-200c mediate suppression of cell motility and anoikis resistance
Howe, E. N., Cochrane, D. R., & Richer, J. K. (2011) · Breast Cancer Research · doi:10.1186/bcr2867 · Cited by 249
Madhavan, D., Zucknick, M., Wallwiener, M., Cuk, K., Modugno, C., Scharpff, M., Schott, S., Heil, J., Turchinovich, A., Yang, R., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1407 · Cited by 249
miR-24 Regulates Apoptosis by Targeting the Open Reading Frame (ORF) Region of FAF1 in Cancer Cells
Qin, W., Shi, Y., Zhao, B., Yao, C., Jin, L., Ma, J., & Jin, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009429 · Cited by 247
Hamano, R., Miyata, H., Yamasaki, M., Kurokawa, Y., Hara, J., Moon, J. H., Nakajima, K., Takiguchi, S., Fujiwara, Y., Mori, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2532 · Cited by 243
Chan, Y. C., Khanna, S., Roy, S., & Sen, C. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158790 · Cited by 237
Jurmeister, S., Baumann, M., Balwierz, A., Keklikoglou, I., Ward, A., Uhlmann, S., Zhang, J. D., Wiemann, S., & Sahin, Ö. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06212-11 · Cited by 229
Suppression of Colon Cancer Metastasis by Aes through Inhibition of Notch Signaling
Sonoshita, M., Aoki, M., Fuwa, H., Aoki, K., Hosogi, H., Sakai, Y., Hashida, H., Takabayashi, A., Sasaki, M., Robine, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.008 · Cited by 209
Xu, Y., Brenn, T., Brown, E. R. S., Doherty, V, & Melton, D. W. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.568 · Cited by 202
Zhu, W., Xu, H., Zhu, D., Zhi, H., Wang, T., Wang, J., Jiang, B., Shu, Y., & Liu, P. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1752-3 · Cited by 199
Uhlmann, S., Zhang, J. D., Schwäger, A., Mannsperger, H., Riazalhosseini, Y., Burmester, S., Ward, A., Korf, U., Wiemann, S., & Sahin, Ö. (2010) · Oncogene · doi:10.1038/onc.2010.201 · Cited by 199
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
Cortez, M. A., Valdecanas, D., Zhang, X., Zhan, Y., Bhardwaj, V., Calin, G. A., Komaki, R., Giri, D. K., Quini, C. C., Wolfe, T., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.79 · Cited by 196
Xia, H., Ng, S. S., Jiang, S., Cheung, W. K. C., Sze, J., Bian, X.-W., Kung, H.-F., & Lin, M. C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.093 · Cited by 193
Lim, Y., Wright, J. A., Attema, J. L., Gregory, P. A., Bert, A. G., Smith, E., Thomas, D., Drew, P. A., Khew-Goodall, Y., & Goodall, G. J. (2013) · Journal of Cell Science · doi:10.1242/jcs.122275 · Cited by 191
Karginov, F. V., Cheloufi, S., Chong, M. M. W., Stark, A., Smith, A. D., & Hannon, G. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.001 · Cited by 186
Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells
Neves, R., Scheel, C., Weinhold, S., Honisch, E., Iwaniuk, K. M., Trompeter, H.-I., Niederacher, D., Wernet, P., Santourlidis, S., & Uhrberg, M. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-219 · Cited by 178
Drake, J. M., Strohbehn, G., Bair, T. B., Moreland, J. G., & Henry, M. D. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-10-1076 · Cited by 177
miR-200 Inhibits Lung Adenocarcinoma Cell Invasion and Metastasis by Targeting Flt1/VEGFR1
Roybal, J. D., Zang, Y., Ahn, Y.-H., Yang, Y., Gibbons, D. L., Baird, B. N., Alvarez, C., Thilaganathan, N., Liu, D. D., Saintigny, P., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0497 · Cited by 174
mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1
Schickel, R., Park, S.-M., Murmann, A. E., & Peter, M. E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.018 · Cited by 167
miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1
Liu, S., Tetzlaff, M. T., Cui, R., & Xu, X. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.07.009 · Cited by 165
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
Cochrane, D. R., Howe, E. N., Spoelstra, N. S., & Richer, J. K. (2010) · Journal of Oncology · doi:10.1155/2010/821717 · Cited by 162
miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression
Tang, H., Deng, M., Tang, Y., Xie, X., Guo, J., Kong, Y., Ye, F., Su, Q., & Xie, X. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1326 · Cited by 160
MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer
Yu, S.-J., Hu, J.-Y., Kuang, X.-Y., Luo, J.-M., Hou, Y.-F., Di, G.-H., Wu, J., Shen, Z.-Z., Song, H.-Y., & Shao, Z.-M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1959 · Cited by 159
Torres, A., Torres, K., Pesci, A., Ceccaroni, M., Paszkowski, T., Cassandrini, P. A., Zamboni, G., & Maciejewski, R. (2012) · International Journal of Cancer · doi:10.1002/ijc.27840 · Cited by 158
Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics
Allen, K. E., & Weiss, G. J. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0397 · Cited by 158
Chan, Y. C., Roy, S., Khanna, S., & Sen, C. K. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.248583 · Cited by 154
Williams, K., Renthal, N. E., Condon, J. C., Gerard, R. D., & Mendelson, C. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200650109 · Cited by 153
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
Valladares‐Ayerbes, M., Reboredo, M., Villaamil, V. M., Iglesias-Díaz, P., Lorenzo-Patiño, M. J., Haz‐Conde, M., Santamarina, I., Blanco, M., Fernandez-Tajes, J. J., Quindós, M., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-186 · Cited by 153
Sun, Y., Shen, S., Liu, X., Tang, H., Wang, Z., Yu, Z., Li, X., & Wu, M. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1950-x · Cited by 152
Wang, Z., Zhao, Y. M., Smith, E., Goodall, G. J., Drew, P. A., Brabletz, T., & Yang, C. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr029 · Cited by 139
Self-citationGenome‐wide identification of miR‐200 targets reveals a regulatory network controlling cell invasion
Bracken, C. P., Li, X., Wright, J. A., Lawrence, D., Pillman, K. A., Salmanidis, M., Anderson, M. A., Dredge, B. K., Gregory, P. A., Tsykin, A., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201488641 · Cited by 139
Schliekelman, M. J., Gibbons, D. L., Faça, V. M., Creighton, C. J., Rizvi, Z. H., Zhang, Q. H., Wong, C., Wang, H., Ungewiss, C., Ahn, Y., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0964 · Cited by 138
Inorganic Arsenite-Induced Malignant Transformation of Human Prostate Epithelial Cells
Achanzar, W. E., Brambila, E., Diwan, B. A., Webber, M. M., & Waalkes, M. P. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.24.1888 · Cited by 137
MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways
Li, X., Roslan, S., Johnstone, C. N., Wright, J. A., Bracken, C. P., Anderson, M. A., Bert, A. G., Selth, L. A., Anderson, R. L., Goodall, G. J., et al. (2013) · Oncogene · doi:10.1038/onc.2013.370 · Cited by 127
Cittelly, D. M., Dimitrova, I. K., Howe, E. N., Cochrane, D. R., Jean, A., Spoelstra, N. S., Post, M. D., Lu, X. J. D., Broaddus, R. R., Spillman, M. A., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0463 · Cited by 126
Li, J., Tan, Q., Yan, M., Liu, L., Lin, H., Zhao, F., Bao, G., Kong, H., Ge, C., Zhang, F., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-166 · Cited by 126
The rejuvenated scenario of epithelial–mesenchymal transition (EMT) and cancer metastasis
Meng, F., & Wu, G. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9379-3 · Cited by 124
Tang, H., Kong, Y., Guo, J., Tang, Y., Xie, X., Yang, L., Su, Q., & Xie, X. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.027 · Cited by 123
Regulation of Vascular Endothelial Growth Factor Signaling by miR-200b
Choi, Y.-C., Yoon, S., Jeong, Y., Yoon, J., & Baek, K. (2011) · Molecules and Cells · doi:10.1007/s10059-011-1042-2 · Cited by 122
miR-200b Inhibits Prostate Cancer EMT, Growth and Metastasis
Williams, L. V., Veliceasa, D., Vinokour, E. I., & Volpert, O. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083991 · Cited by 121
Kopp, F. B., Oak, P., Wagner, E., & Roidl, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050469 · Cited by 121
Liu, L., Qiu, M., Tan, G., Liang, Z., Qin, Y., Chen, L., Chen, H., & Liu, J. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0305-z · Cited by 121
The miR200 Family of MicroRNAs Regulates WAVE3-dependent Cancer Cell Invasion
Sossey‐Alaoui, K., Białkowska, K., & Plow, E. F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034553 · Cited by 116
MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis
Humphries, B. A., Wang, Z., Oom, A. L., Fisher, T., Tan, D., Cui, Y., Jiang, Y., & Yang, C. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu133 · Cited by 113
Self-citationPeng, F., Jiang, J., Yu, Y., Tian, R., Guo, X., Li, X., Shen, M., Xu, M., Zhu, F., Shi, C., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.655 · Cited by 107
MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes
Castilla, M. Á., Díaz‐Martín, J., Sarrió, D., Romero‐Pérez, L., López‐García, M. Á., Vieites, B., Biscuola, M., Ramiro-Fuentes, S., Isacke, C. M., & Palacios, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047709 · Cited by 104
MiR-200c and HuR in ovarian cancer
Prislei, S., Martinelli, E., Mariani, M., Raspaglio, G., Sieber, S. C., Ferrandina, G., Shahabi, S., Scambia, G., & Ferlini, C. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-72 · Cited by 102
Manavalan, T. T., Teng, Y., Litchfield, L. M., Muluhngwi, P., Al-Rayyan, N., & Klinge, C. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062334 · Cited by 100
Peng, C., Li, N., Ng, Y.-K., Zhang, J., Meier, F., Theis, F. J., Merkenschlager, M., Chen, W., Wurst, W., & Prakash, N. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2124-12.2012 · Cited by 100
MicroRNAs Regulate Renal Tubule Maturation through Modulation of Pkd1
Patel, V., Hajarnis, S. S., Williams, D., Hunter, R. W., Huynh, D., & Igarashi, P. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012030321 · Cited by 99
Shi, L., Zhang, S., Wu, H., Zhang, L., Dai, X., Hu, J., Xue, J. F., Liu, T., Liang, Y., & Wu, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078344 · Cited by 98
Lu, Y., Li, Y., Xue, X., Zhou, M., Liu, Y., Zhang, C., Li, J., Zheng, L., Hong, M., & Li, X. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2348 · Cited by 96
Bracken, C. P., Szubert, J. M., Mercer, T. R., Dinger, M. E., Thomson, D. W., Mattick, J. S., Michael, M., & Goodall, G. J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr110 · Cited by 91
Chuang, T., Panda, H., Luo, X., & Chegini, N. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0007 · Cited by 89
Panda, H., Pelakh, L., Chuang, T., Luo, X., Bükülmez, O., & Chegini, N. (2012) · Reproductive Sciences · doi:10.1177/1933719112438448 · Cited by 88
Howe, E. N., Cochrane, D. R., Cittelly, D. M., & Richer, J. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049987 · Cited by 87
Luo, M.-L., Gong, C., Chen, C.-H., Lee, D. Y., Hu, H., Huang, P., Yao, Y., Guo, W., Reinhardt, F., Wulf, G. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2785 · Cited by 86
miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family
Feng, Y., Tang, H., Liu, Q., Xie, X., Wu, M., Liu, X., Chen, B., & Xie, X. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-17 · Cited by 78
Liu, J., Ruan, B., You, N., Huang, Q., Liu, W., Dang, Z., Xu, W., Zhou, T., Ji, R., Cao, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079409 · Cited by 74
Chuang, T., & Khorram, O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095370 · Cited by 72
Wang, Z., Humphries, B. A., Xiao, H., Jiang, Y., & Yang, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554246 · Cited by 70
Self-citationCarroll, A. P., Goodall, G. J., & Liu, B. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1217 · Cited by 70
Wang, Z., Yang, J., Fisher, T., Xiao, H., Jiang, Y., & Yang, C. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1104061 · Cited by 69
Self-citationBimpaki, E. I., Iliopoulos, D., Moraitis, A. G., & Stratakis, C. A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03725.x · Cited by 64
Specificity Protein 1 (Sp1) Maintains Basal Epithelial Expression of the miR-200 Family
Kolesnikoff, N., Attema, J. L., Roslan, S., Bert, A. G., Schwarz, Q., Gregory, P. A., & Goodall, G. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.529172 · Cited by 62
Zhang, H., Zhang, K., Liao, L., Li, L., Du, Z., Wu, B., Wu, J., Xu, X., Zeng, F., Chen, B., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt320 · Cited by 61
Biochemical relapse following radical prostatectomy and miR‐200a levels in prostate cancer
Barron, N., Keenan, J., Gammell, P., Martínez, V. G., Freeman, A., Masters, J. R., & CLYNES, M. M. (2011) · The Prostate · doi:10.1002/pros.22469 · Cited by 56
miR-200c and GATA binding protein 4 regulate human embryonic stem cell renewal and differentiation
Huang, H.-N., Chen, S.-Y., Hwang, S., Yu, C.-C., Su, M., Mai, W., Wang, H., Cheng, W., Schuyler, S. C., Ma, N. J.-L., et al. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.11.009 · Cited by 56
Zhang, X., Zhang, B., Gao, J., Wang, X., & Liu, Z. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478016 · Cited by 55
miR-200b targets GATA-4 during cell growth and differentiation
Yao, C.-X., Wei, Q.-X., Zhang, Y., Wang, W.-P., Xue, L., Yang, F., Zhang, S., Xiong, C.-J., Li, W., Wei, Z., et al. (2013) · RNA Biology · doi:10.4161/rna.24370 · Cited by 51
Wang, Z., Humphries, B. A., Xiao, H., Jiang, Y., & Yang, C. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.04.018 · Cited by 42
Self-citationSUZ12 Depletion Suppresses the Proliferation of Gastric Cancer Cells
Cui, Y., Chen, J., He, Z., & Xiao, Y. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350095 · Cited by 40
Liao, C., Chen, W., Fan, X., Jiang, X., Qiu, L., Chen, C., Zhu, Y., & Wang, H. (2014) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504013x13832473329999 · Cited by 38
Tao, T., Liu, D., Liu, C., Xu, B., Chen, S., Yin, Y., Ang, L., Huang, Y., Zhang, X., & Chen, M. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.07.001 · Cited by 30
MiR-200c Regulates Noxa Expression and Sensitivity to Proteasomal Inhibitors
Lerner, M., Haneklaus, M., Harada, M., & Grandér, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036490 · Cited by 30
Gill, J. G., Langer, E. M., Lindsley, R. C., Cai, M., Murphy, T. L., & MURPHY, K. M. M. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0194 · Cited by 27
Li, R., He, J., Chen, X.-M., Long, C., Yang, D.-H., Ding, Y., Qi, H., & Liu, X. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3045-5 · Cited by 16
Cited by
Circular RNA: a new star of noncoding RNAs
Qu, S., Yang, X., Li, X., Wang, J., Gao, Y., Shang, R., Sun, W., Dou, K., & Li, H. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.003 · Cited by 1,808
Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells
Vafadar, A., Shabaninejad, Z., Movahedpour, A., Fallahi, F., Taghavipour, M., Ghasemi, Y., Akbari, M., Shafiee, A., Hajighadimi, S., Moradizarmehri, S., et al. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00397-0 · Cited by 296
Circular RNAs: a new frontier in the study of human diseases
Chen, Y., Li, C., Tan, C., & Liu, X. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103758 · Cited by 293
The Endometriotic Tumor Microenvironment in Ovarian Cancer
Wendel, J. R. H., Wang, X., & Hawkins, S. M. (2018) · Cancers · doi:10.3390/cancers10080261 · Cited by 51
Metadata
- Authors
- Humphries, B., & Yang, C.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-01-30
- Volume
- 6
- Issue
- 9
- Pages
- 6472-6498
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2165616810
- Cited by
- 346
- References
- 147
- FWCI
- 11.78
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.